Dave Diebolt has extensive experience in the pharmaceutical industry, specializing in rheumatology and immunology roles. Notable positions include Patient Access Manager at Horizon from October 2016 to February 2020 and Senior Acthar Specialist at Mallinckrodt Pharmaceuticals from August 2014 to June 2015. Diebolt's career features significant contributions to companies such as Wyeth, where responsibilities included managing market strategies for Enbrel, and UCB Pharma, focusing on sales of monoclonal antibodies for autoimmune diseases. Currently, Diebolt serves as an Executive Immunology Sales Specialist at AstraZeneca, building on a robust background in sales management and market development across various therapeutic areas.
This person is not in the org chart
This person is not in any teams
This person is not in any offices